aluates Reports

$ 0.0

Automative

Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-10N13538

Global Drug Eluting Beads Microcatheters and Radiopaque Beads in Interventional Oncology Market Research Report 2023

BUY CHAPTERS

Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Research Report 2025

Code: QYRE-Auto-10N13538

Report

June 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott Laboratories (Abbott EP)

ABK Biomedical, Inc.

Boston Scientific Corporation

BTG Plc

Cook Medical Inc

Medtronic Inc

Merit Medical Systems Inc

Stryker Corporation

TriSalus Life Sciences

Terumo Corporation

Vascular Solutions, Inc.

Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market

The global market for Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology.

The Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Report

Report Metric	Details
Report Name	Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market
CAGR	5%
Segment by Type	Chemotherapeutic Agent Radiation Therapy Drug-eluting Particles
Segment by Application	Hospitals Specialty Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories (Abbott EP), ABK Biomedical, Inc., Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Medtronic, Inc., Merit Medical Systems, Inc., Stryker Corporation, TriSalus Life Sciences, Terumo Corporation, Vascular Solutions, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market report?

Ans: The main players in the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market are Abbott Laboratories (Abbott EP), ABK Biomedical, Inc., Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Medtronic, Inc., Merit Medical Systems, Inc., Stryker Corporation, TriSalus Life Sciences, Terumo Corporation, Vascular Solutions, Inc.

What are the Application segmentation covered in the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market report?

Ans: The Applications covered in the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market report are Hospitals, Specialty Clinics

What are the Type segmentation covered in the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market report?

Ans: The Types covered in the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market report are Chemotherapeutic Agent, Radiation Therapy, Drug-eluting Particles

Recommended Reports

Interventional Oncology Devices

Drug-Eluting Technologies

Therapy & Delivery Innovations

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Chemotherapeutic Agent

1.2.3 Radiation Therapy

1.2.4 Drug-eluting Particles

1.3 Market by Application

1.3.1 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Perspective (2020-2031)

2.2 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Growth Trends by Region

2.2.1 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Historic Market Size by Region (2020-2025)

2.2.3 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Forecasted Market Size by Region (2026-2031)

2.3 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Dynamics

2.3.1 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Industry Trends

2.3.2 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Drivers

2.3.3 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Challenges

2.3.4 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Players by Revenue

3.1.1 Global Top Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Players by Revenue (2020-2025)

3.1.2 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share by Players (2020-2025)

3.2 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue

3.4 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Concentration Ratio

3.4.1 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in 2024

3.5 Global Key Players of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Head office and Area Served

3.6 Global Key Players of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology, Product and Application

3.7 Global Key Players of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Breakdown Data by Type

4.1 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Historic Market Size by Type (2020-2025)

4.2 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Forecasted Market Size by Type (2026-2031)

5 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Breakdown Data by Application

5.1 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Historic Market Size by Application (2020-2025)

5.2 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size (2020-2031)

6.2 North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2020-2025)

6.4 North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size (2020-2031)

7.2 Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2020-2025)

7.4 Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size (2020-2031)

8.2 Asia-Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Region (2020-2025)

8.4 Asia-Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size (2020-2031)

9.2 Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2020-2025)

9.4 Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size (2020-2031)

10.2 Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2020-2025)

10.4 Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories (Abbott EP)

11.1.1 Abbott Laboratories (Abbott EP) Company Details

11.1.2 Abbott Laboratories (Abbott EP) Business Overview

11.1.3 Abbott Laboratories (Abbott EP) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.1.4 Abbott Laboratories (Abbott EP) Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.1.5 Abbott Laboratories (Abbott EP) Recent Development

11.2 ABK Biomedical, Inc.

11.2.1 ABK Biomedical, Inc. Company Details

11.2.2 ABK Biomedical, Inc. Business Overview

11.2.3 ABK Biomedical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.2.4 ABK Biomedical, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.2.5 ABK Biomedical, Inc. Recent Development

11.3 Boston Scientific Corporation

11.3.1 Boston Scientific Corporation Company Details

11.3.2 Boston Scientific Corporation Business Overview

11.3.3 Boston Scientific Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.3.4 Boston Scientific Corporation Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.3.5 Boston Scientific Corporation Recent Development

11.4 BTG plc

11.4.1 BTG plc Company Details

11.4.2 BTG plc Business Overview

11.4.3 BTG plc Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.4.4 BTG plc Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.4.5 BTG plc Recent Development

11.5 Cook Medical, Inc.

11.5.1 Cook Medical, Inc. Company Details

11.5.2 Cook Medical, Inc. Business Overview

11.5.3 Cook Medical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.5.4 Cook Medical, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.5.5 Cook Medical, Inc. Recent Development

11.6 Medtronic, Inc.

11.6.1 Medtronic, Inc. Company Details

11.6.2 Medtronic, Inc. Business Overview

11.6.3 Medtronic, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.6.4 Medtronic, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.6.5 Medtronic, Inc. Recent Development

11.7 Merit Medical Systems, Inc.

11.7.1 Merit Medical Systems, Inc. Company Details

11.7.2 Merit Medical Systems, Inc. Business Overview

11.7.3 Merit Medical Systems, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.7.4 Merit Medical Systems, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.7.5 Merit Medical Systems, Inc. Recent Development

11.8 Stryker Corporation

11.8.1 Stryker Corporation Company Details

11.8.2 Stryker Corporation Business Overview

11.8.3 Stryker Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.8.4 Stryker Corporation Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.8.5 Stryker Corporation Recent Development

11.9 TriSalus Life Sciences

11.9.1 TriSalus Life Sciences Company Details

11.9.2 TriSalus Life Sciences Business Overview

11.9.3 TriSalus Life Sciences Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.9.4 TriSalus Life Sciences Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.9.5 TriSalus Life Sciences Recent Development

11.10 Terumo Corporation

11.10.1 Terumo Corporation Company Details

11.10.2 Terumo Corporation Business Overview

11.10.3 Terumo Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.10.4 Terumo Corporation Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.10.5 Terumo Corporation Recent Development

11.11 Vascular Solutions, Inc.

11.11.1 Vascular Solutions, Inc. Company Details

11.11.2 Vascular Solutions, Inc. Business Overview

11.11.3 Vascular Solutions, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Introduction

11.11.4 Vascular Solutions, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

11.11.5 Vascular Solutions, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories (Abbott EP)

ABK Biomedical, Inc.

Boston Scientific Corporation

BTG Plc

Cook Medical Inc

Medtronic Inc

Merit Medical Systems Inc

Stryker Corporation

TriSalus Life Sciences

Terumo Corporation

Vascular Solutions, Inc.

List of Tables

Table 1. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Chemotherapeutic Agent

Table 3. Key Players of Radiation Therapy

Table 4. Key Players of Drug-eluting Particles

Table 5. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Region (2020-2025)

Table 9. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Region (2026-2031)

Table 11. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Trends

Table 12. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Drivers

Table 13. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Challenges

Table 14. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Restraints

Table 15. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Players (2020-2025)

Table 17. Global Top Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology as of 2024)

Table 18. Ranking of Global Top Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology, Headquarters and Area Served

Table 21. Global Key Players of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology, Product and Application

Table 22. Global Key Players of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share by Type (2020-2025)

Table 26. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share by Type (2026-2031)

Table 28. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share by Application (2020-2025)

Table 30. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share by Application (2026-2031)

Table 32. North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 47. Abbott Laboratories (Abbott EP) Company Details

Table 48. Abbott Laboratories (Abbott EP) Business Overview

Table 49. Abbott Laboratories (Abbott EP) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 50. Abbott Laboratories (Abbott EP) Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 51. Abbott Laboratories (Abbott EP) Recent Development

Table 52. ABK Biomedical, Inc. Company Details

Table 53. ABK Biomedical, Inc. Business Overview

Table 54. ABK Biomedical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 55. ABK Biomedical, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 56. ABK Biomedical, Inc. Recent Development

Table 57. Boston Scientific Corporation Company Details

Table 58. Boston Scientific Corporation Business Overview

Table 59. Boston Scientific Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 60. Boston Scientific Corporation Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 61. Boston Scientific Corporation Recent Development

Table 62. BTG plc Company Details

Table 63. BTG plc Business Overview

Table 64. BTG plc Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 65. BTG plc Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 66. BTG plc Recent Development

Table 67. Cook Medical, Inc. Company Details

Table 68. Cook Medical, Inc. Business Overview

Table 69. Cook Medical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 70. Cook Medical, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 71. Cook Medical, Inc. Recent Development

Table 72. Medtronic, Inc. Company Details

Table 73. Medtronic, Inc. Business Overview

Table 74. Medtronic, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 75. Medtronic, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 76. Medtronic, Inc. Recent Development

Table 77. Merit Medical Systems, Inc. Company Details

Table 78. Merit Medical Systems, Inc. Business Overview

Table 79. Merit Medical Systems, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 80. Merit Medical Systems, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 81. Merit Medical Systems, Inc. Recent Development

Table 82. Stryker Corporation Company Details

Table 83. Stryker Corporation Business Overview

Table 84. Stryker Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 85. Stryker Corporation Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 86. Stryker Corporation Recent Development

Table 87. TriSalus Life Sciences Company Details

Table 88. TriSalus Life Sciences Business Overview

Table 89. TriSalus Life Sciences Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 90. TriSalus Life Sciences Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 91. TriSalus Life Sciences Recent Development

Table 92. Terumo Corporation Company Details

Table 93. Terumo Corporation Business Overview

Table 94. Terumo Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 95. Terumo Corporation Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 96. Terumo Corporation Recent Development

Table 97. Vascular Solutions, Inc. Company Details

Table 98. Vascular Solutions, Inc. Business Overview

Table 99. Vascular Solutions, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product

Table 100. Vascular Solutions, Inc. Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025) & (US$ Million)

Table 101. Vascular Solutions, Inc. Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Picture

Figure 2. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Type: 2024 VS 2031

Figure 4. Chemotherapeutic Agent Features

Figure 5. Radiation Therapy Features

Figure 6. Drug-eluting Particles Features

Figure 7. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Specialty Clinics Case Studies

Figure 11. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Report Years Considered

Figure 12. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Region: 2024 VS 2031

Figure 15. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Players in 2024

Figure 16. Global Top Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in 2024

Figure 18. North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Country (2020-2031)

Figure 20. United States Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Country (2020-2031)

Figure 24. Germany Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Region (2020-2031)

Figure 32. China Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Country (2020-2031)

Figure 40. Mexico Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Share by Country (2020-2031)

Figure 44. Turkey Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Abbott Laboratories (Abbott EP) Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 48. ABK Biomedical, Inc. Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 49. Boston Scientific Corporation Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 50. BTG plc Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 51. Cook Medical, Inc. Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 52. Medtronic, Inc. Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 53. Merit Medical Systems, Inc. Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 54. Stryker Corporation Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 55. TriSalus Life Sciences Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 56. Terumo Corporation Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 57. Vascular Solutions, Inc. Revenue Growth Rate in Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350